Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory ...
The bad news for Philadelphia is that these advantages are being squandered by leadership that can’t translate assets into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback